Antititin antibody in early- and late-onset myasthenia gravis. (Q54343444)

28 May 2018

http://europepmc.org/abstract/MED/24947881

title

Antititin antibody in early- and late-onset myasthenia gravis. (English)

1 reference

28 May 2018

http://europepmc.org/abstract/MED/24947881

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947881%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Malgorzata Dutkiewicz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947881%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

7

N E Gilhus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947881%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

B Szyluk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947881%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

M Lipowska

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947881%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

B Ryniewicz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947881%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

J Kubiszewska

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947881%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

A Kostera-Pruszczyk

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947881%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

English

0 references

publication date

20 June 2014

1 reference

28 May 2018

http://europepmc.org/abstract/MED/24947881

published in

Acta Neurologica Scandinavica

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947881%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947881%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947881%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

229-233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947881%20AND%20SRC:MED&resulttype=core&format=json

Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value

9 June 2020

cites work

1 reference

The occurrence of anti-titin antibodies and thymomas: a population survey of MG 1970-1999.

21 January 2018

1 reference

Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients

21 January 2018

1 reference

Thymectomy and Antimuscle Antibodies in Nonthymomatous Myasthenia Gravis

21 January 2018

1 reference

Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis

21 January 2018

1 reference

Different characteristic phenotypes according to antibody in myasthenia gravis

21 January 2018

1 reference

Guidelines for treatment of autoimmune neuromuscular transmission disorders

21 January 2018

1 reference

Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

Epidemiologic evidence for a changing natural history of myasthenia gravis

21 January 2018

1 reference

Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey

21 January 2018

1 reference

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America

21 January 2018

1 reference

Muscle autoantibodies in subgroups of myasthenia gravis patients

21 January 2018

1 reference

Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?

21 January 2018

1 reference

Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?

21 January 2018

1 reference

The ageing and myasthenic thymus: a morphometric study validating a standard procedure in the histological workup of thymic specimens

21 January 2018

1 reference

The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes

21 January 2018

1 reference

Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis

21 January 2018

1 reference

Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study

21 January 2018

1 reference

Anterior mediastinal tumors: diagnostic accuracy of CT and MRI.

21 January 2018

1 reference

CT and myasthenia gravis: correlation between mediastinal imaging and histopathological findings.

21 January 2018

1 reference

Thymic lesions and myasthenia gravis. Diagnosis based on mediastinal imaging and pathological findings

21 January 2018

1 reference

The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis

21 January 2018

1 reference

Classification of Myasthenia Gravis Based on Autoantibody Status

21 January 2018

1 reference

Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ANE.12271

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24947881%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference